Atea Pharmaceuticals, Inc. (AVIR)

3.155 +0.02 (+0.48%) USD  |  NASDAQ  |  Dec 10, 14:46
More

Atea Pharmaceuticals Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for AVIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade
KORU Medical Systems, Inc. Upgrade
Erasca, Inc. Upgrade
Coya Therapeutics, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade